Table of Contents
ISRN Hematology
Volume 2011, Article ID 974609, 6 pages
http://dx.doi.org/10.5402/2011/974609
Case Report

Clonal Hypereosinophilic Syndrome: Two Cases Report in Black Men from Sub-Saharan Africa and Literature Reviews

1Medical Faculty and Hematology Laboratory of the Campus Teaching Hospital of Lomé, Lomé, Togo
2Medical Faculty and Hematology Laboratory of Tokoin Teaching Hospital of Lomé, Lomé, Togo

Received 3 January 2011; Accepted 24 January 2011

Academic Editor: C. Hallermann

Copyright © 2011 Kodjovi Messie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. J. Bain, “Hypereosinophilia,” Current Opinion in Hematology, vol. 7, no. 1, pp. 21–25, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. M. J. Chusid, D. C. Dale, B. C. West, and S. M. Wolff, “The hypereosinophilic syndrome. Analysis of fourteen cases with review of the literature,” Medicine, vol. 54, no. 1, pp. 1–27, 1975. View at Google Scholar · View at Scopus
  3. “Myeloproliferative disorders : WHO classification of chronic myeloproliferative diseases,” in Oxford Handbook of Clinical Heamatology, p. 238, 2nd edition, 2008.
  4. D. Berild, H. Hasselbalch, and J. Heyn, “The hypereosinophilic syndrome,” Ugeskrift for Laeger, vol. 146, no. 33, pp. 2473–2477, 1984. View at Google Scholar · View at Scopus
  5. B. J. Bain, “Relationship between idiopathic hypereosinophilic syndrome, eosinophilic leukemia, and systemic mastocytosis,” American Journal of Hematology, vol. 77, no. 1, pp. 82–85, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. A. D. Klion, J. Robyn, C. Akin et al., “Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome,” Blood, vol. 103, no. 2, pp. 473–478, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. F. Talarmin, F. Y. Hounto, P. S. M'Baye, B. Abraham, H. Morel, and D. Charles, “Difficulties in diagnosing idiopathic hypereosinophilic syndrome in Black Africa. A case report observed in Senegal,” Tropical Medicine, vol. 54, pp. 145–148, 1994. View at Google Scholar
  8. G. J. Gleich, K. M. Leiferman, A. Pardanani, A. Tefferi, and J. H. Butterfield, “Treatment of hypereosinophilic syndrome with imatinib mesilate,” Lancet, vol. 359, no. 9317, pp. 1577–1578, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. Cools, D. J. DeAngelo, J. Gotlib et al., “A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome,” New England Journal of Medicine, vol. 348, no. 13, pp. 1201–1214, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. Resnick and R. M. Myerson, “Hypereosinophilic syndrome. Report of two cases, with prolonged courses,” The American Journal of Medicine, vol. 51, no. 4, pp. 560–564, 1971. View at Google Scholar · View at Scopus
  11. J. Alijotas Reig, R. Serra Juanpere, R. Nogués Boqueras, and M. Dalmau Ciria, “Ecchymosis and hepatomegaly as the presenting form of an idiopathic hypereosinophilic syndromeEquimosis y hepatomegalia como forma de presentación de un síndrome hipereosinofílico idiopático,” Revista Clinica Espanola, vol. 183, no. 1, p. 50, 1988. View at Google Scholar · View at Scopus
  12. M. Arquati, V. Amodei, P. Foa, and A. Tedeschi, “Autoimmune hemolytic anemia in a patient with idiopathic hypereosinophilia,” American Journal of Hematology, vol. 49, no. 4, p. 356, 1995. View at Google Scholar · View at Scopus
  13. A. Aida and M. Horimoto, “A case of hypereosinophilic syndrome exhibiting left ventricular systolic dysfunction,” Respiration and Circulation, vol. 40, no. 11, pp. 1123–1127, 1992. View at Google Scholar · View at Scopus
  14. R. H. Felman, D. B. Sutherland, J. L. Conklin, and F. A. Mitros, “Eosinophilic cholecystitis, appendiceal inflammation, pericarditis, and cephalosporin-associated eosinophilia,” Digestive Diseases and Sciences, vol. 39, no. 2, pp. 418–422, 1994. View at Google Scholar · View at Scopus
  15. M. Buitenhuis, L. P. Verhagen, J. Cools, and P. J. Coffer, “Molecular mechanisms underlying FIP1L1-PDGFRA-mediated myeloproliferation,” Cancer Research, vol. 67, no. 8, pp. 3759–3766, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. R. Bigoni, A. Cuneo, M. G. Roberti et al., “Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome,” Haematologica, vol. 85, no. 5, pp. 486–491, 2000. View at Google Scholar · View at Scopus
  17. S. Fletcher and B. Bain, “Diagnosis and treatment of hypereosinophilic syndromes,” Current Opinion in Hematology, vol. 14, no. 1, pp. 37–42, 2007. View at Google Scholar · View at Scopus
  18. F. Brito-Babapulle, “The eosinophilias, including the idiopathic hypereosinophilic syndrome,” British Journal of Haematology, vol. 121, no. 2, pp. 203–223, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Ionescu, H. Murata, and A. Janin, “Oral mucosa lesions in hypereosinophilic syndrome—an update,” Oral Diseases, vol. 14, no. 2, pp. 115–122, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. E. J. Steer and N. C. P. Cross, “Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor beta,” Acta Haematologica, vol. 107, no. 2, pp. 113–122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Martin, R. Ott, and H. G. Klues, “Idiopathic hypereosinophilia with cardiac involvementIdiopathische hypereosinophilie mit kardialer beteiligung,” Deutsche Medizinische Wochenschrift, vol. 129, no. 11, pp. 557–560, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. N. von Bubnoff, M. Sandherr, G. Schlimok, R. Andreesen, C. Peschel, and J. Duyster, “Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia,” Leukemia, vol. 19, no. 2, pp. 286–287, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. J. H. Griffin, J. Leung, R. J. Bruner, M. A. Caligiuri, and R. Briesewitz, “Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7830–7835, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. T. Sherrod and H. R. Schumacher, “Philadelphia chromosome-negative CML with eosinophils?” American Journal of Clinical Pathology, vol. 82, no. 5, p. 633, 1984. View at Google Scholar · View at Scopus
  25. P. M. Moore, J. B. Harley, and A. S. Fauci, “Neurologic dysfunction in the idiopathic hypereosinophilic syndrome,” Annals of Internal Medicine, vol. 102, no. 1, pp. 109–114, 1985. View at Google Scholar · View at Scopus
  26. D. T. Durack, S. M. Sumi, and S. J. Klebanoff, “Neurotoxicity of human eosinophils,” Proceedings of the National Academy of Sciences of the United States of America, vol. 76, no. 3, pp. 1443–1447, 1979. View at Google Scholar · View at Scopus
  27. O. Bletry, C. Scheuble, and P. Cereze, “Cardiac manifestations of the hypereosinophilic syndrome. The value of 2-dimensional echography (12 cases),” Archives des Maladies du Coeur et des Vaisseaux, vol. 77, no. 6, pp. 633–641, 1984. View at Google Scholar
  28. Véronique D-H. Recherche de réarrangement FIP1L1-PDGFRA, Ph.D. thesis, Université Paris Diderot, Paris 7, 2006.
  29. C. Walz, G. Metzgeroth, C. Haferlach et al., “Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene,” Haematologica, vol. 92, no. 2, pp. 163–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. Z. Salem, P. A. Zalloua, A. Chehal et al., “Effective treatment of hypereosinophilic syndrome with imatinib mesylate,” Hematology Journal, vol. 4, no. 6, pp. 410–412, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus